Literature DB >> 22235130

Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.

Kekulawalage Gauthamadasa1, Nataraja Sarma Vaitinadin, James L Dressman, Stephen Macha, Reyn Homan, Kenneth D Greis, R A Gangani D Silva.   

Abstract

It is well accepted that HDL has the ability to reduce risks for several chronic diseases. To gain insights into the functional properties of HDL, it is critical to understand the HDL structure in detail. To understand interactions between the two major apolipoproteins (apos), apoA-I and apoA-II in HDL, we generated highly defined benchmark discoidal HDL particles. These particles were reconstituted using a physiologically relevant phospholipid, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) incorporating two molecules of apoA-I and one homodimer of apoA-II per particle. We utilized two independent mass spectrometry techniques to study these particles. The techniques are both sensitive to protein conformation and interactions and are namely: 1) hydrogen deuterium exchange combined with mass spectrometry and 2) partial acetylation of lysine residues combined with MS. Comparison of mixed particles with apoA-I only particles of similar diameter revealed that the changes in apoA-I conformation in the presence of apoA-II are confined to apoA-I helices 3-4 and 7-9. We discuss these findings with respect to the relative reactivity of these two particle types toward a major plasma enzyme, lecithin:cholesterol acyltransferase responsible for the HDL maturation process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22235130      PMCID: PMC3293592          DOI: 10.1074/jbc.M111.291070

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.

Authors:  Philip Barter; John Kastelein; Alistair Nunn; Richard Hobbs
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

2.  Speciated human high-density lipoprotein protein proximity profiles.

Authors:  Kekulawalage Gauthamadasa; Corina Rosales; Henry J Pownall; Stephen Macha; W Gray Jerome; Rong Huang; R A Gangani D Silva
Journal:  Biochemistry       Date:  2010-11-23       Impact factor: 3.162

3.  Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.

Authors:  J E Buring; G T O'Connor; S Z Goldhaber; B Rosner; P N Herbert; C B Blum; J L Breslow; C H Hennekens
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

4.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

5.  Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein.

Authors:  Dale D O Martin; Madhu S Budamagunta; Robert O Ryan; John C Voss; Michael N Oda
Journal:  J Biol Chem       Date:  2006-05-11       Impact factor: 5.157

6.  Intermolecular contact between globular N-terminal fold and C-terminal domain of ApoA-I stabilizes its lipid-bound conformation: studies employing chemical cross-linking and mass spectrometry.

Authors:  Shaila Bhat; Mary G Sorci-Thomas; Eric T Alexander; Michael P Samuel; Michael J Thomas
Journal:  J Biol Chem       Date:  2005-06-22       Impact factor: 5.157

7.  The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle.

Authors:  D M Durbin; A Jonas
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

8.  Topographic study of arrestin using differential chemical modifications and hydrogen/deuterium exchange.

Authors:  H Ohguro; K Palczewski; K A Walsh; R S Johnson
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

9.  Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.

Authors:  Corina Rosales; Baiba K Gillard; Harry S Courtney; Francisco Blanco-Vaca; Henry J Pownall
Journal:  Biochemistry       Date:  2009-08-25       Impact factor: 3.162

10.  Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study.

Authors:  G Roselli della Rovere; A Lapolla; G Sartore; C Rossetti; S Zambon; N Minicuci; G Crepaldi; D Fedele; E Manzato
Journal:  Nutr Metab Cardiovasc Dis       Date:  2003-02       Impact factor: 4.222

View more
  10 in total

1.  Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein.

Authors:  Timothy J Sontag; Ronald Carnemolla; Tomas Vaisar; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2012-03-08       Impact factor: 5.922

2.  Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1.

Authors:  John T Melchior; Scott E Street; Allison B Andraski; Jeremy D Furtado; Frank M Sacks; Rebecca L Shute; Emily I Greve; Debi K Swertfeger; Hailong Li; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Lipid Res       Date:  2017-05-05       Impact factor: 5.922

3.  A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL.

Authors:  Allison L Cooke; Jamie Morris; John T Melchior; Scott E Street; W Gray Jerome; Rong Huang; Andrew B Herr; Loren E Smith; Jere P Segrest; Alan T Remaley; Amy S Shah; Thomas B Thompson; W Sean Davidson
Journal:  J Lipid Res       Date:  2018-05-17       Impact factor: 5.922

Review 4.  New insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolism.

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2012-12-10       Impact factor: 5.922

5.  Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  Biochemistry       Date:  2012-06-01       Impact factor: 3.162

6.  Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.

Authors:  Monica Gomaraschi; Alice Ossoli; Samuela Castelnuovo; Sara Simonelli; Chiara Pavanello; Gloria Balzarotti; Marcello Arca; Alessia Di Costanzo; Tiziana Sampietro; Gaetano Vaudo; Damiano Baldassarre; Fabrizio Veglia; Guido Franceschini; Laura Calabresi
Journal:  J Lipid Res       Date:  2017-03-28       Impact factor: 5.922

7.  Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity.

Authors:  Eric T Alexander; Michael C Phillips
Journal:  J Lipid Res       Date:  2013-10-01       Impact factor: 5.922

8.  Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.

Authors:  Linda S May-Zhang; Valery Yermalitsky; Jiansheng Huang; Tiffany Pleasent; Mark S Borja; Michael N Oda; W Gray Jerome; Patricia G Yancey; MacRae F Linton; Sean S Davies
Journal:  J Biol Chem       Date:  2018-04-30       Impact factor: 5.157

Review 9.  Applications of hydrogen/deuterium exchange MS from 2012 to 2014.

Authors:  Gregory F Pirrone; Roxana E Iacob; John R Engen
Journal:  Anal Chem       Date:  2014-11-14       Impact factor: 6.986

10.  Predictive Value of Second-Trimester Maternal Lipid Profiling in Early-Onset Pre-eclampsia: A Prospective Cohort Study and Nomogram.

Authors:  Juan Li; Juefei Lu; Mengni Wang; Wen Hu; Neng Jin; Xingmiao Li; Baihui Zhao; Qiong Luo
Journal:  Front Med (Lausanne)       Date:  2021-12-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.